Center for Devices and Radiological Health (CDRH) looks at privatisation:
This article was originally published in Clinica
The US FDA's Center for Devices & Radiological Health (CDRH) is trying to unload some of its cargo before Congress decides to scuttle the whole CDRH ship. Center officials are looking at a number of options for privatisation, including "routine inspections", CDRH director Bruce Burlington told a Capitol Hill conference on May 22nd. The Center has already agreed to a pilot programme for outside premarket review of some device applications. A public meeting on the subject is scheduled for June 19th.
You may also be interested in...
The International Generic and Biosimilar Medicines Association has urged the World Intellectual Property Organization to withdraw its support for a global database of pharmaceutical patent information. The Pat-INFORMED database – which is comprised of intellectual-property information provided by originators – contains unverified data and lacks appropriate safeguards, the IGBA contends.
Reforms to the US 180-day exclusivity incentive included in the Blocking Act that is part of the Lower Health Care Costs Act could cost the US healthcare system approximately $1.7bn, the AAM has warned.